公司資料
SIGA Technologies Inc 股價、新聞與催化劑
- 股票代碼:
- SIGA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.35 USD (-1.47%)
收盤價
最後更新: 2026年10月1日
310M USD
市值
股價為何變動
截至 2026年10月1日，SIGA 下跌 1.47%，收於 $3.35。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
SIGA Technologies is a specialty pharmaceutical company best known for its antiviral countermeasure portfolio, especially against orthopox and smallpox-related threats. Its story is tied to government procurement and biodefense demand.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, SIGA sits in specialty pharmaceuticals and biodefense.
商業模式特徵
The company depends on government contracts, product supply, and the economics of public-health preparedness rather than broad commercial volume.
生技產業定位
SIGA is a niche biodefense name whose stock is driven by contract timing and preparedness spending.
未來催化劑
- SIGA Technologies’ catalysts are TPOXX procurement, biodefense contract cadence, and any government-demand update tied to smallpox preparedness. This is a contract-driven story, so procurement timing matters more than clinical readouts.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。